Skip to main content
. 2018 Dec 7;20(1):6–16. doi: 10.1002/acm2.12441

Figure 4.

Figure 4

Transit dosimetry point dose measurements on: (a) breast; and (b) lung cancer patients treated between 2011 and 2016.